Diwakar Davar

This study tests a treatment made from healthy donor gut bacteria (MTP-101-C) for people with cancer who have severe skin or gut side effects from immunotherapy that did not improve with steroids. The goal is to see if this microbiome therapy can safely control these side effects…

This study tests whether a transplant of healthy gut bacteria (from donor stool) combined with the immunotherapy drug pembrolizumab can help people with advanced lung cancer that has stopped responding to standard treatments. About 26 participants will receive the bacteria transp…

This study tests a drug called tebentafusp in people with a specific genetic type (HLA-A*0201) who have untreated metastatic uveal melanoma, a rare eye cancer that has spread. The trial uses a blood test to track tumor DNA and measure response. About 44 participants will receive …

This study looks at whether people with certain cancers prefer getting their immunotherapy (nivolumab or pembrolizumab) as a shot under the skin or as an IV drip. About 880 patients will try both methods and say which they like better. The goal is to understand patient preference…